- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01517542
Evaluation of Effectiveness of Nutritional Counseling in Patients After Stroke
September 9, 2021 updated by: SHEILA CRISTINA OURIQUES MARTINS, Hospital de Clinicas de Porto Alegre
Evaluation on the Effectiveness of Nutritional Counseling on an Adapted DASH Diet in Patients After Stroke: a Randomized Clinical Trial
Stroke is the leading cause of disability worldwide and the leading cause of death in Brazil.
It is estimated that about 18 million people will have a stroke in 2015 and approximately one third of these resulting in death.
The factors most important modifiable risk for stroke include high blood pressure (hypertension), diabetes, smoking, dyslipidemia, sedentary lifestyle and obesity.
Acting on these risk factors can be reduced by 88% the risk of another stroke.
Healthy eating is among the changes in lifestyle that are recommended for prevention and treatment of one of the main risk factors for stroke.
Studies show that the adoption of the DASH diet can significantly reduce blood pressure and the result is even more significant in hypertensive patients, making this diet a new alternative in the prevention and treatment of hypertension and consequently stroke.
Compliance therapy is a determining factor for success in the treatment of chronic diseases.
Adherence to long-term treatment in developed countries is around 50% and in developing countries the rates are even lower.
The aim of this study is to evaluate the effectiveness of nutritional counseling in an adapted DASH style diet on body weight, glycemic control, blood pressure values and improved lipid profile compared to the usual diet without nutritional counseling in patients with stroke within the last 3 months.
The hypothesis is that nutritional counseling with an adapted DASH style diet reduces cardiovascular risk factors compared with the usual diet without nutritional counseling in patients with stroke within 3 months.
The stroke patients will be selected in the hospitalization or in the outpatient clinic of Hospital de Clínicas de Porto Alegre in a period up to 3 months after ischemic stroke.
The patients will be randomized to one of the 2 groups.
In the first visit they will be submitted to a social class and international physical activity questionnaire and they will be submitted to a food frequency questionnaire, measures of weight, height, waist circumference, hip and neck, blood pressure and cholesterol and glucose measurements at the baseline, 30 days and 3, 6, 9 and 12 months.
The main endpoints will be the change in the body weight, blood glucose, blood pressure values and lipid profile.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The study will be followed by a evaluation of other endpoints: new stroke, myocardial infarction or cardiovascular death.
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ischemic Stroke up to 3 months
- Modified Rankin Score < 4
Exclusion Criteria:
- Aphasia
- Enteral diet
- Unavailability to follow up the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nutritional counseling
It was composed by patients who received specific written orientation to follow the DASH diet recommendations.
Calories were calculated with the goal of maintaining body weight and divided into 3 main meals and two to three snacks.
|
2 groups: 1 with nutritional counseling and other with usual diet without nutritional counseling
Other Names:
|
|
No Intervention: Usual diet
It was composed by patients who were stimulated to follow the general orientations of the neurologist or keep their food intake habits
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline arterial blood pressure and 6 months
Time Frame: 30 days and 3, 6, 9 and 12 months
|
The patients will be randomized to one of the 2 groups (with nutritional counseling and no intervention - habitual diet).
The main endpoint will be the change in the blood pressure values and adherence to treatment measured in 30 days and 3, 6, 9 and 12 months.
|
30 days and 3, 6, 9 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lipids from baseline
Time Frame: 30 days, 3, 6, 9 and 12 months
|
The patients will be randomized to one of the 2 groups (with nutritional counseling and no intervention - habitual diet).
The secundary endpoint will be the change in the lipid profile and adherence to treatment measured in 30 days and 3, 6, 9 and 12 months.
|
30 days, 3, 6, 9 and 12 months
|
|
Change in the body weight
Time Frame: 30 days and 3, 6, 9 and 12 months
|
The patients will be randomized to one of the 2 groups (with nutritional counseling and no intervention - habitual diet).
The secundary endpoint will be the change in the body weight measured in 30 days and 3, 6, 9 and 12 months.
|
30 days and 3, 6, 9 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sheila CO Martins, PI, Hospital de Clínicas de Porto Alegre
- Study Director: Vanessa A Piper, SI, Hospital de Clínicas de Porto Alegre
- Study Chair: Márcia LF Chaves, SI, Hospital de Clínicas de Porto Alegre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2010
Primary Completion (Anticipated)
September 1, 2021
Study Completion (Anticipated)
September 1, 2021
Study Registration Dates
First Submitted
November 22, 2011
First Submitted That Met QC Criteria
January 24, 2012
First Posted (Estimate)
January 25, 2012
Study Record Updates
Last Update Posted (Actual)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 9, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-0014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Nutritional Counseling
-
Charite University, Berlin, GermanyCompletedIBS - Irritable Bowel SyndromeGermany
-
King Edward Medical UniversityActive, not recruitingCachexia; Cancer; SarcopeniaPakistan
-
Hospital de Clinicas de Porto AlegreActive, not recruitingBinge-Eating Disorder | Cognitive Behavioral Therapy | Transcranial Direct Current StimulationBrazil
-
University of PadovaFondazione Guido Berlucchi; Veneto Institute of Oncology I.O.V.-I.R.C.C.S.Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
William Carey UniversityUniversity of Mississippi Medical Center; University of Southern MississippiCompletedSpinal Cord InjuriesUnited States
-
Société des Produits Nestlé (SPN)CompletedPicky Eating BehaviorsChina
-
Emanuele CeredaCompletedNutritional SupportItaly
-
Montefiore Medical CenterRecruiting
-
Medical University of GrazRecruitingDepressive Disorder | Sleep | Psychological Stress | Nutritional Quality | Burn-out SyndromeAustria